NETWORKED CAPITAL
Lorem ipsum dolor sit amet, consectetur adipiscing. Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.
Recent News
Portfolio company CareAlign featured in Penn Medicine Press Release
February 9, 2022
Study: Care Orchestration System Developed at Penn Medicine Widely Adopted, Easy to Use Read the full press release here. Read the study here. To learn more about CareAlign, visit their website at: https://carealign.ai
Learn More
Portfolio company Regenosine receives a $1.67M NIH NIAMS Phase II SBIR grant
November 9, 2021
Congratulations to portfolio company Regenosine on receiving a $1.67M NIH NIAMS Phase II SBIR grant to commercially develop their disease modifying osteoarthritis drug. Read more here.
Learn MoreOur Address
